Effect of cinacalcet cessation on hyperparathyroidism in kidney transcaplant patients after long-term dialysis therapy

[1] Bonarek H(1999)Reduced parathyroid functional mass after successful kidney transplantation Kidney Int. 56 642-649

[2] Merville P(2011)Natural history of mineral and bone disorders after living-donor kidney transplantation: a 1-year prospective observational study Ther Apher Dial. 15 481-487

[3] Bonarek M(2011)Renal allograft failure in a hyperparathyroid patient following initiation of a calcimimetic Nat Rev Nephrol. 7 237-241

[4] Kawarazaki H(2007)Cinacalcet-associated graft dysfunction and nephrocalcinosis in a kidney transplant recipient Am J Med. 120 e7-e9

[5] Shibagaki Y(2007)Hypercalciuria induced by a high dose of cinacalcet in a renal-transplant recipient Clin Nephrol. 68 245-248

[6] Fukumoto S(2012)Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study Clin Transpl. 26 393-402

[7] Seikrit C(2010)The effects of discontinuing cinacalcet at the time of kidney transplantation NDT Plus. 3 37-41

[8] Muhlfeld A(2009)Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on dialysis Transpl Proc. 41 2396-2398

[9] Groene HJ(1997)The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor J Clin Invest. 100 2977-2983

[10] Floege J(2007)The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands Am J Physiol Ren Physiol. 292 F1390-F1395

[1] Bonarek H(1999)Reduced parathyroid functional mass after successful kidney transplantation Kidney Int. 56 642-649

[2] Merville P(2011)Natural history of mineral and bone disorders after living-donor kidney transplantation: a 1-year prospective observational study Ther Apher Dial. 15 481-487

[3] Bonarek M(2011)Renal allograft failure in a hyperparathyroid patient following initiation of a calcimimetic Nat Rev Nephrol. 7 237-241

[4] Kawarazaki H(2007)Cinacalcet-associated graft dysfunction and nephrocalcinosis in a kidney transplant recipient Am J Med. 120 e7-e9

[5] Shibagaki Y(2007)Hypercalciuria induced by a high dose of cinacalcet in a renal-transplant recipient Clin Nephrol. 68 245-248

[6] Fukumoto S(2012)Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study Clin Transpl. 26 393-402

[7] Seikrit C(2010)The effects of discontinuing cinacalcet at the time of kidney transplantation NDT Plus. 3 37-41

[8] Muhlfeld A(2009)Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on dialysis Transpl Proc. 41 2396-2398

[9] Groene HJ(1997)The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor J Clin Invest. 100 2977-2983

[10] Floege J(2007)The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands Am J Physiol Ren Physiol. 292 F1390-F1395